Navigation Links
Hydroxycut(R) Litigation Focus of July 28 Conference in San Francisco
Date:6/12/2009

SAN FRANCISCO, June 12 /PRNewswire/ -- The Hydroxycut(R) controversy - according to noted plaintiff attorney Vance Andrus - has all the characteristics of the "next big one" - the next massive products litigation for plaintiff attorneys. But Iovate Health Sciences Inc., maker of the myriad Hydroxycut weight-loss and muscle-building products, says the FDA's accounting of adverse event reports is "small relative to the many millions of people who have used Hydroxycut products."

HB Litigation Conferences, formerly Mealey's Conferences, is holding a half-day seminar - titled Hydroxycut(R) Litigation Conference - at the Mission Bay Conference Center at the University of California in San Francisco on Tuesday, July 28, 2009.

Designed to educate plaintiff and defense attorneys, companies and insurers, the program is being chaired by Vance Andrus of Andrus Boudreaux PLC in New Orleans and leading California trial attorney Thomas Girardi of Girardi & Keese in Los Angeles.

Annesley DeGaris of Cory Watson Crowder & Degaris P.C. of Birmingham, Ala., will detail the products and ingredients. DeGaris noted on a recent HB teleconference that there were 14 Hydroxycut(R) product lines for weight loss supplements and within those lines, there were 56 variations based on quantity, size and flavor.

Anne Andrews of Andrews & Thornton in Irvine, Calif., will provide an overview of the $23.7 billion dietary supplement industry, including the history of Hydroxycut(R) maker Iovate / Muscletech.

A "Panel Defendants' Forum" will address lessons from Ephedra, distributors, ingredient makers, jurisdiction and consolidation. Moderated by Thomas Clark of Andrus Boudreaux, panelists are John Boundas of Williams Kherkher Hart Boundas in Houston; Annesley DeGaris of Cory, Watson; and Neil Overholtz of Aylstock, Witkin, Kreis & Overholtz in Pensacola, Fla.

Thomas Clark said during a recent HB teleconference that from January to October 2007, there were 298 adverse event reports made to the FDA regarding dietary supplements. That number grew to 948 for the same period in 2008. Of those reports, Clark said, 596 were mandatory reports by the industry. The FDA estimates that there are 50,000 adverse events from dietary supplements each year, but less than 5% of these are being reported, Clark explained. "This rises to a whole new level of under-reporting," he said, in part because individual consumers either do not connect their symptoms with the supplements or do not tell their doctors they are taking them.

Dr. Andrew Klein, MD, FACS, MBA, director of the Comprehensive Transplant Center at Cedars-Sinai in Los Angeles and David Vermont of Ashcraft & Gerel in Washington, D.C., will provide a review of the medical and scientific aspects of liver, kidney and cardiovascular injuries, alleged to be caused by these supplements.

Lori Andrus of Andrus Anderson in San Francisco and Robert Gordon of Weitz & Luxenberg in New York will provide a perspective on case screening, client retention, case management, and medical record review and testing.

Iovate itself says that it has more than 750 items sold in more than 70 countries, and they "undertake extensive medical, scientific and toxicological literature reviews on the safety of the ingredients during the development stage of each product. Additionally," a May 1 statement from the company continues, "third-party experts from the leading independent scientific firm specializing in ingredient assessment, toxicology and product safety for the nutritional and pharmaceutical industry review the safety of Iovate's ingredients and formulas before products are introduced in the marketplace. Only after this external review is completed does Iovate release a formula."

An article written for Calliope Media states that approximately 127 million adults in the U.S. are overweight, with 60 million classified as obese, and 9 million as severely obese (source: The American Obesity Association). In 2004, 18.9% Americans reported that they had taken one or more dietary supplements in the past year (source: the Institute of Medicine). By 2007, 68% of Americans used dietary supplements, a 2% growth from the previous year (source: Ipsos-Public Affairs for the Council for Responsible Nutrition). Retail and non-retail sales of dietary supplement products across all distribution channels in the U.S. were $17 billion in 2000 (source: The Nutrition Business Journal, 2001).

Calliope Media, which owns An Attorney for You, on May 1, 2009 started looking for people injured by Iovate Health Sciences Inc.'s dietary supplements. Within four weeks, more than 2,300 Hydroxycut(R) case leads were generated by the firm for plaintiff attorneys.

To obtain articles or recordings from HB programs, and for more information about the July 28, 2009, Hydroxycut(R) Litigation Conference, contact HB Litigation Conferences by phone at (484) 324-2755, by email at info@litigationconferences.com, or by visiting the conferences section of HB's website at www.LitigationConferences.com.

HB Litigation Conferences has been producing high-end litigation events since 1992. Its president, Tom Hagy, is former publisher of Mealey Publications and vice president at LexisNexis. Sharon Boothe, HB's vice president, has been the conference director since the company's first program on lead paint litigation in 1992.

    CONTACT
    Sharon Boothe
    Vice President
    (484) 324-2755 x208
    Sharon.Boothe@LitigationConferences.com


'/>"/>
SOURCE HB Litigation Conferences
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Fenwal Statement Regarding Patent Litigation
2. Niutang Sucralose Patent Litigation Successfully Concluded
3. LawInfo Provides Access to Qualified Hydroxycut Litigation Attorneys Nationwide
4. Court Rules in Favor of HealthSouth in Litigation Involving General Medicine, P.C.
5. Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
6. Jonathan Perkins Injury Lawyers Adds Two Experienced Litigation Attorneys to Connecticut Team
7. Benzene Litigation Conference July 24
8. Chinese Drywall Litigation Subject of Conference and Two Teleconferences
9. Blue Cross Reverses Position on Autism After Federal Court Litigation Intensifies
10. HB Litigation Conferences Announces Conference and Two Teleconferences on Chinese Drywall Litigation and Insurance
11. Par Pharmaceutical Enters Into Agreement With Reliant Pharmaceuticals to Settle Patent Litigation Over Rythmol(R) SR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... MENLO PARK, Calif. , Oct. 11, 2017 /PRNewswire/ ... a national scientific team that developed an innovative way ... and quantity of the delivery of new drugs. ... the 2017 Fall Clinical Dermatology Conference will show how ... Massachusetts General Hospital, Harvard Medical School used a suite ...
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
Breaking Medicine Technology: